We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A black and white image of Carol Houts, smiling at the camera. She is wearing black glasses and a dark-coloured blazer, and has long blonde hair.

Carol Houts profile page

Chief Strategy and Commercial Officer

 at Germfree Laboratories

Carol Houts serves as chief strategy and commercial officer at Germfree Laboratories, where she leverages her cross-functional expertise to lead global commercial strategy, M&A and integrated solutions. She has positioned Germfree at the forefront of decentralized and modular biomanufacturing, delivering mobile and modular cleanrooms, specialized equipment and services that support advanced therapies, hospital compounding and infectious-disease preparedness. Known as a strategic force who blends clinical, quality and commercial expertise, Houts is dedicated to building innovative organizations that expand global patient access to life-saving therapies.


Got a Question for Carol Houts?

Get in touch using the contact form linked here and we'll get back to you shortly.



Content Written By, Reviewed By, or Featuring Carol Houts
Total: 4
Glowing AI icon emerging from persons hand with other icons linking to AI around it.
Article

How Is AI Shaping the Future of Automated Labs?

Experts shared their insights with Technology Networks, offering a glimpse into a future where automation and intelligence work hand in hand.
Illustration of scientists in purple lab coats working together on an experiment.
Article

How Is Collaboration Driving Life Science Innovation?

Where do the greatest opportunities for collaboration across life sciences disciplines lie today – and what’s needed to unlock them? We asked the experts.
Five scientists in white lab coats standing looking at a camera with their arms folded.
Article

What One Change Does Life Sciences Need? We Asked the Experts

What single change could most accelerate progress across the field? We asked leading researchers, innovators and policy experts to share their perspectives.
A variety of different blister packets containing drug pills and tablets.
Industry Insight

Can the US End Its Reliance on Offshore Drug Manufacturing?

Explore how onshoring pharmaceutical manufacturing could reshape US drug production and boost supply chain resilience.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter